{"id":"https://openalex.org/W4416638075","doi":"https://doi.org/10.1183/13993003.congress-2025.pa5693","title":"Patient reported improvement in dyspnea and physical inactivity with Budesonide/Glycopyrronium/Formoterol (BGF): AIR-FORCE*study","display_name":"Patient reported improvement in dyspnea and physical inactivity with Budesonide/Glycopyrronium/Formoterol (BGF): AIR-FORCE*study","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416638075","doi":"https://doi.org/10.1183/13993003.congress-2025.pa5693"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa5693","doi":"https://doi.org/10.1183/13993003.congress-2025.pa5693","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa5693","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031845084","display_name":"Saiprasad Patil","orcid":"https://orcid.org/0009-0006-6035-681X","observed_orcids":["https://orcid.org/0009-0006-6035-681X"]},"institutions":[{"id":"https://openalex.org/I4210131532","display_name":"Glenmark Pharmaceuticals (India)","ror":"https://ror.org/037fhg487","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210131532"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Saiprasad Patil","raw_affiliation_strings":["1Global Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Global Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210131532"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Divya Bhojwani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131532","display_name":"Glenmark Pharmaceuticals (India)","ror":"https://ror.org/037fhg487","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210131532"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Divya Bhojwani","raw_affiliation_strings":["1Global Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Global Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210131532"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101559034","display_name":"Deependra Kumar Rai","orcid":"https://orcid.org/0000-0001-9090-8124","observed_orcids":["https://orcid.org/0000-0001-9090-8124"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deependra Kumar Rai","raw_affiliation_strings":["2Dept. of Pulmonary Medicine, AIIMS, Patna, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dept. of Pulmonary Medicine, AIIMS, Patna, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070489582","display_name":"Hanmant V. Barkate","orcid":"https://orcid.org/0000-0003-4346-9194","observed_orcids":["https://orcid.org/0000-0003-4346-9194"]},"institutions":[{"id":"https://openalex.org/I4210131532","display_name":"Glenmark Pharmaceuticals (India)","ror":"https://ror.org/037fhg487","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210131532"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Hanmant Barkate","raw_affiliation_strings":["1Global Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Global Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210131532"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079746705","display_name":"Sagar Bhimrao Bhagat","orcid":"https://orcid.org/0000-0002-3513-4944","observed_orcids":["https://orcid.org/0000-0002-3513-4944"]},"institutions":[{"id":"https://openalex.org/I4210131532","display_name":"Glenmark Pharmaceuticals (India)","ror":"https://ror.org/037fhg487","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210131532"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sagar Bhagat","raw_affiliation_strings":["1Global Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Global Medical Affairs, Glenmark Pharmaceuticals Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210131532"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA5693","last_page":"PA5693"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.8769999742507935},{"id":"https://openalex.org/keywords/dyspnea","display_name":"dyspnea","score":0.7710000276565552},{"id":"https://openalex.org/keywords/physical-inactivity","display_name":"physical inactivity","score":0.9620000123977661},{"id":"https://openalex.org/keywords/budesonide-glycopyrronium-formoterol","display_name":"budesonide/glycopyrronium/formoterol","score":0.9259999990463257},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/dry-powder-inhaler","display_name":"dry powder inhaler","score":0.8209999799728394},{"id":"https://openalex.org/keywords/pressurized-metered-dose-inhaler","display_name":"pressurized metered-dose inhaler","score":0.8980000019073486},{"id":"https://openalex.org/keywords/mmrc-dyspnea-scale","display_name":"mMRC dyspnea scale","score":0.8330000042915344},{"id":"https://openalex.org/keywords/symptom-improvement","display_name":"symptom improvement","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9498999714851379},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.614799976348877},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.5490999817848206},{"id":"https://openalex.org/C2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","level":2,"score":0.35920000076293945},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.34439998865127563},{"id":"https://openalex.org/C3020255362","wikidata":"https://www.wikidata.org/wiki/Q747883","display_name":"Physical activity","level":2,"score":0.334199994802475},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.3228999972343445},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.31360000371932983},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.2863999903202057},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.2849000096321106},{"id":"https://openalex.org/C79544238","wikidata":"https://www.wikidata.org/wiki/Q423243","display_name":"Activities of daily living","level":2,"score":0.28220000863075256},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.2802000045776367},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26339998841285706},{"id":"https://openalex.org/C2983914783","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Lung disease","level":3,"score":0.26260000467300415},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.2603999972343445},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.2596000134944916}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa5693","doi":"https://doi.org/10.1183/13993003.congress-2025.pa5693","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa5693","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416637731","https://openalex.org/W4416639269","https://openalex.org/W4411194318","https://openalex.org/W3177182840","https://openalex.org/W4200074920","https://openalex.org/W7171654157","https://openalex.org/W2905962528","https://openalex.org/W4404098550","https://openalex.org/W3193811270","https://openalex.org/W2970110245"],"abstract_inverted_index":{"Introduction:":[0],"Disabling":[1,60],"breathlessness":[2,61],"is":[3],"common":[4],"manifestation":[5],"of":[6,23,95,174,185],"COPD":[7,39,186],"characterized":[8],"by":[9],"difficulty":[10],"in":[11,182],"walking,":[12],"preventing":[13],"patients":[14,40,75,128,149],"from":[15,150],"leaving":[16],"home.":[17],"Aim:":[18],"To":[19],"assess":[20],"the":[21,77,170,183],"effectiveness":[22],"BGF":[24,43,142],"DPI/pMDI":[25,143],"on":[26,38],"dyspnea":[27,108,115,121,132,146],"severity":[28],"and":[29,136,172],"physical":[30],"inactivity":[31],"Method:":[32],"A":[33],"prospective,multi-centric":[34],"study":[35,167],"was":[36,62,70],"conducted":[37],"treated":[41],"with":[42,82,98,155],"DPI":[44],"(400/25/12mcg)/pMDI":[45],"(160/9/4.8mcg)":[46],"after":[47],"ethics":[48],"approval":[49],"(CTRI/2023/10/058675).Clinical":[50],"assessments":[51],"were":[52,80],"done":[53],"at":[54],"baseline,":[55,88],"weeks":[56],"4,12":[57],"&":[58],"24.":[59],"identified":[63],"as":[64],"mMRC":[65],"score":[66],"\u22652,":[67],"while":[68,111],"non-disabling":[69,131],"mMRC<2.":[71],"Results:":[72],"Among":[73],"182":[74,90],"completed":[76],"study,":[78],"70.6%":[79],"male":[81],"mean":[83],"age":[84],"53.71\u00b19.7":[85],"years.":[86],"At":[87],"all":[89],"had":[91,106,113,119,138],"disabling":[92,157],"breathlessness,":[93],"regardless":[94],"prior":[96],"treatment":[97],"LABA/LAMA":[99],"(34.7%)":[100],"or":[101],"ICS/LABA":[102],"(65.2%).":[103],"Most,":[104],"76.9%":[105],"moderate":[107],"(mMRC":[109,116,122],"2-3)":[110],"23.0%":[112],"severe":[114,139,151],"4).":[117],"None":[118],"mild":[120],"0-1).":[123],"After":[124],"24":[125],"weeks,":[126],"42.3%":[127],"improved":[129],"to":[130,152,168],"(p<0.001)":[133],"(Figure":[134],"1)":[135],"none":[137],"dyspnea.":[140,158],"Conclusion:":[141],"significantly":[144],"reduced":[145],"severity,":[147],"transitioning":[148],"moderate/mild":[153],"symptoms":[154],"no":[156],"*AIR-FORCE":[159],"study:":[160],"An":[161],"Open":[162],"label":[163],"SIngle":[164],"arm,Multicentric,PRospective":[165],"PhaseIV":[166],"evaluate":[169],"Safety":[171],"EFfectiveness":[173],"GlycOpyrronium/":[175],"FoRmoterol":[176],"fumarate/":[177],"Budesonide":[178],"triple":[179],"therapy":[180],"(TT)":[181],"management":[184],"patiEnts.":[187],"erj;66/suppl_69/PA5693/F1":[188],"F1":[189,190]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-11-25T00:00:00"}